path_3008_sm_supportinginforFigS1.tif2202KSupporting Information: Figure S1. Depletion of endogenous STOML2 decreases migration and invasion of primary glioma cells (PGCs).
path_3008_sm_supportinginforFigS2.tif70KSupporting Information: Figure S2 Statistical significance of the difference between curves of STOML2 high-expressing and low-expressing patients was compared within subgroups of WHO grade II (left panel), WHO grade III (middle panel), and WHO grade IV (right panel).
path_3008_sm_supportinginforTS1.doc37KSupporting Information: Table S1. Clinicopathological characteristics of patient samples and expression of STOML2 in gliomas.
path_3008_sm_supportinginforSupp.doc34KSupporting Information: Supplementary materials and methods.
path_3008_sm_supportinginforFigCap.doc22KSupporting Information: Legends to Figure S1 to S2

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.